Miguel Ángel Cabrera-Pérez (Miguel-Ángel Cabrera-Pérez)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 9

Top Venues

Journal of chemical information and modeling

Pharmaceutics

AAPS PharmSciTech

Expert opinion on drug discovery

Universidad Central Marta Abreu de las Villas

Universidad Central Marta Abreu de las Villas (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad Central Marta Abreu de las Villas Sep 03 1993

Cuba

Head of Modeling and Experimental Biopharmaceutics Unit :: Centro de Bioactivos Químicos

Education History

Universidad Central Marta Abreu de las Villas

Cuba

PHD :: Centro de Bioactivos Químicos

Universidad de la Habana

Cuba

MSC :: Instituto de Farmacia y Alimentos

Instituto Superior de Tecnologías y Ciencias Aplicadas

Cuba

BSC

Publications

Claudia Miranda, Alejandro Ruiz-Picazo, Paula Pomares, Isabel González-Álvarez, Marival Bermejo, Marta González-Álvarez, Alex Avdeef, Miguel Ángel Cabrera-Pérez
Integration of In Silico, In Vitro and In Situ Tools for the Preformulation and Characterization of a Novel Cardio-Neuroprotective Compound during the Early Stages of Drug Development. Pharmaceutics 14 (1) (2022)
Claudia Miranda, Alexis Aceituno, Mirna Fernández, Gustavo Mendes, Yanina Rodríguez, Verónica Llauró, Miguel Ángel Cabrera-Pérez
ICH Guideline for Biopharmaceutics Classification System-Based Biowaiver (M9): Toward Harmonization in Latin American Countries. Pharmaceutics 13 (3) (2021)
Omar Casanova-Alvarez, Aliuska Morales-Helguera, Miguel Ángel Cabrera-Pérez, Reinaldo Molina-Ruiz, Christophe Molina
A Novel Automated Framework for QSAR Modeling of Highly Imbalanced Leishmania High-Throughput Screening Data. Journal of chemical information and modeling 61 (7) (2021)
Claudia Miranda-Pérez de Alejo, Alexis Aceituno Álvarez, Gustavo Mendes Lima Santos, Mirna Fernández Cervera, Helgi Jung-Cook, Miguel Ángel Cabrera-Pérez
Policy of Multisource Drug Products in Latin America: Opportunities and Challenges on the Application of Bioequivalence In Vitro Assays. Therapeutic innovation & regulatory science 55 (1) (2020)
Gabriela Falcón-Cano, Christophe Molina, Miguel Ángel Cabrera-Pérez
ADME Prediction with KNIME: Development and Validation of a Publicly Available Workflow for the Prediction of Human Oral Bioavailability. Journal of chemical information and modeling 60 (6) (2020)
Gabriela Falcón-Cano, Christophe Molina, Miguel Ángel Cabrera-Pérez
ADME prediction with KNIME: In silico aqueous solubility consensus model based on supervised recursive random forest approaches. ADMET & DMPK 8 (3) (2020)
Miguel Ángel Cabrera-Pérez, Hai Pham-The, Mirna Fernández Cervera, Rosario Hernández-Armengol, Claudia Miranda-Pérez de Alejo, Yudileidy Brito-Ferrer
Integrating theoretical and experimental permeability estimations for provisional biopharmaceutical classification: Application to the WHO essential medicines. Biopharmaceutics & drug disposition 39 (7) (2018)
Claudia Miranda, Zenia Pérez-Rodríguez, Rosario Hernández-Armengol, Yaidel Quiñones-García, Tania Betancourt-Purón, Miguel Ángel Cabrera-Pérez
Biowaiver or Bioequivalence: Ambiguity in Sildenafil Citrate BCS Classification. AAPS PharmSciTech 19 (4) (2018)
Miguel Ángel Cabrera-Pérez, Pham-The Hai
Computational modeling of human oral bioavailability: what will be next? Expert opinion on drug discovery 13 (6) (2018)

Miguel Ángel Cabrera-Pérez.css-eqlu8i{font-size:small;padding-left:4px;} (Miguel-Ángel Cabrera-Pérez)

Publication Activity (10 Years)

Top Topics

Top Venues

Miguel Ángel Cabrera-Pérez (Miguel-Ángel Cabrera-Pérez)